Carrier-Mediated Transport of H1-Antagonist at the Blood-Brain Barrier: A Common Transport System of H1-Antagonists and Lipophilic Basic Drugs

Masahiro Yamazaki, Tetsuya Terasaki, Kuniaki Yoshioka, Osamu Nagata, Hideo Kato, Yasuo Ito, Akira Tsuji

研究成果: Article査読

39 被引用数 (Scopus)


The blood-brain barrier (BBB) transport system for H1 antagonists was studied using primary cultured bovine brain capillary endothelial cells (BCEC). The uptake of [3H]mepyramine was inhibited by various H1-antagonists. Ketotifen competitively inhibited [3H]mepyramine uptake with an inhibition constant (Ki ) of 46.8 µM. Lipophilic basic drugs such as propranolol, lidocaine and imipramine significantly inhibited [3H]mepyramine uptake. In particular, propranolol inhibited [3H]mepyramine uptake competitively at an inhibition constant (Ki) of 51.1 µM. Moreover, in ATP-depleted BCEC, [3H]mepyramine uptake was stimulated by preloading with H1- antagonists and lipophilic basic drugs. These results indicated that H1-antagonists are transported across the BBB via a carrier-mediated transport system common to lipophilic basic drugs.

ジャーナルPharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists
出版ステータスPublished - 1994 11

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry
  • Pharmacology (medical)

フィンガープリント 「Carrier-Mediated Transport of H<sub>1</sub>-Antagonist at the Blood-Brain Barrier: A Common Transport System of H<sub>1</sub>-Antagonists and Lipophilic Basic Drugs」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。